Malignancy and mortality in paediatric ‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
Alimentary Pharmacology&Therapeutics, EarlyView.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: M. E. Joosse
,
M. A. Aardoom
,
P. Kemos
,
D. Turner
,
D. C. Wilson
,
S. Koletzko
,
J. Martin ‐de‐Carpi
,
U. L. Fagerberg
,
C. Spray
,
C. Tzivinikos
,
M. Sladek
,
R. Shaoul
,
E. Roma‐Giannikou
,
J. Bronsky
,
D. E. Serban
, Source Type: research
More News: Cancer & Oncology | Drugs & Pharmacology | Inflammatory Bowel Disease | Pediatrics | Study